News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
108,161 Results
Type
Article (4254)
Company Profile (18)
Press Release (103889)
Section
Business (31975)
Career Advice (108)
Deals (5249)
Drug Delivery (5)
Drug Development (5402)
Employer Resources (11)
FDA (3199)
Job Trends (2080)
News (46962)
Policy (3873)
Tag
Academia (363)
Allergies (9)
Alliances (11182)
ALS (6)
Alzheimer's disease (316)
Antibody-drug conjugate (ADC) (5)
Approvals (3210)
Artificial intelligence (90)
Autoimmune disease (1)
Automation (4)
Bankruptcy (46)
Best Places to Work (1722)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (10)
Bladder cancer (11)
Brain cancer (6)
Breast cancer (63)
Cancer (438)
Cardiovascular disease (26)
Career advice (99)
Career pathing (1)
CAR-T (9)
Cell therapy (24)
Cervical cancer (7)
Clinical research (4190)
Collaboration (180)
Compensation (16)
COVID-19 (481)
C-suite (38)
Cystic fibrosis (9)
Data (258)
Decentralized trials (1)
Depression (6)
Diabetes (17)
Diagnostics (5821)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (14)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (5)
Earnings (10498)
Employer branding (2)
Employer resources (11)
Events (13584)
Executive appointments (114)
FDA (3389)
Fibrodysplasia Ossificans Progressiva (1)
Funding (125)
Gene editing (1)
Generative AI (8)
Gene therapy (14)
GLP-1 (40)
Government (624)
Guidances (8)
Healthcare (2908)
IgA nephropathy (1)
Immunology and inflammation (6)
Indications (2)
Infectious disease (510)
Inflammatory bowel disease (12)
Influenza (12)
Intellectual property (7)
Interviews (12)
IPO (1797)
IRA (1)
Job creations (401)
Job search strategy (94)
Kidney cancer (5)
Labor market (1)
Layoffs (24)
Leadership (1)
Legal (535)
Liver cancer (11)
Lung cancer (48)
Lymphoma (33)
Machine learning (2)
Management (3)
Manufacturing (44)
MASH (5)
Medical device (2462)
Medtech (2462)
Mergers & acquisitions (3543)
Metabolic disorders (35)
Multiple sclerosis (20)
NASH (3)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (374)
NextGen: Class of 2025 (703)
Non-profit (547)
Now hiring (2)
Obesity (13)
Opinion (11)
Ovarian cancer (13)
Pain (4)
Pancreatic cancer (10)
Parkinson's disease (15)
Partnered (3)
Patents (22)
Patient recruitment (9)
Peanut (4)
People (8994)
Pharmaceutical (1)
Phase I (1262)
Phase II (1756)
Phase III (1612)
Pipeline (145)
Policy (2)
Postmarket research (212)
Preclinical (591)
Press Release (11)
Prostate cancer (38)
Psychedelics (1)
Radiopharmaceuticals (120)
Rare diseases (29)
Real estate (864)
Recruiting (5)
Regulatory (3019)
Reports (10)
Research institute (426)
Resumes & cover letters (15)
Rett syndrome (1)
Schizophrenia (1)
Series A (15)
Series B (12)
Service/supplier (2)
Sickle cell disease (1)
Spinal muscular atrophy (10)
Sponsored (5)
Startups (623)
Stomach cancer (2)
Supply chain (6)
The Weekly (1)
Vaccines (41)
Venture capitalists (6)
Weight loss (4)
Women's health (6)
Date
Today (23)
Last 7 days (112)
Last 30 days (380)
Last 365 days (4861)
2025 (1669)
2024 (5118)
2023 (6128)
2022 (10214)
2021 (9619)
2020 (8993)
2019 (6151)
2018 (4855)
2017 (5402)
2016 (5394)
2015 (6112)
2014 (4630)
2013 (4126)
2012 (4434)
2011 (4630)
2010 (4080)
Location
Africa (131)
Alabama (6)
Alaska (1)
Arizona (58)
Arkansas (2)
Asia (5341)
Australia (1251)
California (793)
Canada (262)
China (33)
Colorado (56)
Connecticut (63)
Delaware (7)
Europe (15218)
Florida (105)
Georgia (38)
Idaho (4)
Illinois (105)
India (4)
Indiana (34)
Iowa (4)
Japan (23)
Kansas (11)
Kentucky (4)
Louisiana (1)
Maine (20)
Maryland (102)
Massachusetts (426)
Michigan (65)
Minnesota (75)
Missouri (28)
Montana (4)
Nebraska (8)
Nevada (1)
New Hampshire (18)
New Jersey (147)
New Mexico (17)
New York (302)
North Carolina (183)
North Dakota (6)
Northern California (362)
Ohio (31)
Oklahoma (2)
Oregon (7)
Pennsylvania (83)
Rhode Island (5)
South America (154)
South Carolina (4)
Southern California (291)
Tennessee (31)
Texas (180)
United States (3181)
Utah (85)
Virginia (37)
Washington D.C. (6)
Washington State (76)
Wisconsin (32)
108,161 Results for "sekisui diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SEKISUI Diagnostics to Provide Metrix® COVID/Flu Test to the Point-of-Care and Home Test Markets
April 3, 2025
·
3 min read
Genetown
SEKISUI Diagnostics Receives Emergency Use Authorization for the OSOM® Flu SARS-CoV-2 Combo Test
SEKISUI Diagnostics, a global medical diagnostics manufacturer, has received EUA clearance for the OSOM Flu SARS-CoV-2 Combo Test for use in professional and home testing settings.
March 5, 2024
·
2 min read
Business
SEKISUI Diagnostics and Aptitude Partner to Provide Metrix™ COVID-19 Tests to the Point-of-Care and Home Test Markets
SEKISUI Diagnostics, a global medical diagnostics manufacturer, has formalized an exclusive distribution agreement with Aptitude Medical Systems (Aptitude™), an innovative developer of decentralized molecular diagnostics, to sell the Aptitude Metrix™ COVID-19 Test in the U.S.
January 3, 2024
·
3 min read
Press Releases
SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity
November 15, 2024
·
2 min read
Genetown
SEKISUI Diagnostics announces the Launch of the OSOM® COVID-19 Antigen Home Test
SEKISUI Diagnostics announces the launch of the OSOM COVID-19 Antigen Home Test to diagnose COVID-19 at home.
July 31, 2023
·
2 min read
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform signed a contract research agreement with SEKISUI CHEMICAL CO., LTD..
January 23, 2024
·
2 min read
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
·
4 min read
·
BioSpace Insights
Press Releases
Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk
April 25, 2025
·
6 min read
Press Releases
Cleveland Diagnostics Announces Landmark Longitudinal Study Published in Urology
April 23, 2025
·
3 min read
Press Releases
Newly-formed Archerfish Precision Diagnostics Pte Ltd: Ushers a New Era in Advanced Diagnostics
March 6, 2025
·
5 min read
1 of 10,817
Next
